WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.6% of their position (1K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $1.4K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/7/2023ACC: 0001213900-23-094145
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+1K
Net shares
Net buyer
$1.4K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+600.00
Price / share
$1.39
Trade value
$834.00
% of position
0.4%
12/5/2023
167.12K→167.72K
Common Stock
Direct
Shares
+76.00
Price / share
$1.34
Trade value
$101.84
% of position
0.0%
12/6/2023
167.72K→167.80K
Common Stock
Direct
Shares
+324.00
Price / share
$1.36
Trade value
$440.64
% of position
0.2%
12/7/2023
167.80K→168.12K
Total
Net shares
+1K
Net value
$1.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2023 | P · Purchase | +600.00 | $1.39 | $834.00 | 0.4% | 167.12K | 167.72K |
| Common Stock Direct | 12/6/2023 | P · Purchase | +76.00 | $1.34 | $101.84 | 0.0% | 167.72K | 167.80K |
| Common Stock Direct | 12/7/2023 | P · Purchase | +324.00 | $1.36 | $440.64 | 0.2% | 167.80K | 168.12K |
| Total | +1K | $1.38K | ||||||
Derivative Transactions0
No derivative transactions reported